Hong Kong · Delayed Price · Currency is HKD Innovent Biologics Statistics
Total Valuation
HKG:1801 has a market cap or net worth of HKD 135.60 billion. The enterprise value is 128.85 billion.
| Market Cap | 135.60B |
| Enterprise Value | 128.85B |
Important Dates
The next estimated earnings date is Wednesday, March 25, 2026.
| Earnings Date | Mar 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:1801 has 1.72 billion shares outstanding. The number of shares has increased by 3.74% in one year.
| Current Share Class | 1.72B |
| Shares Outstanding | 1.72B |
| Shares Change (YoY) | +3.74% |
| Shares Change (QoQ) | +3.84% |
| Owned by Insiders (%) | 6.45% |
| Owned by Institutions (%) | 34.39% |
| Float | 1.60B |
Valuation Ratios
The trailing PE ratio is 106.59 and the forward PE ratio is 47.46.
| PE Ratio | 106.59 |
| Forward PE | 47.46 |
| PS Ratio | 10.83 |
| PB Ratio | 8.58 |
| P/TBV Ratio | 9.49 |
| P/FCF Ratio | 85.48 |
| P/OCF Ratio | 68.13 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 93.01, with an EV/FCF ratio of 81.22.
| EV / Earnings | 103.85 |
| EV / Sales | 10.29 |
| EV / EBITDA | 93.01 |
| EV / EBIT | 135.98 |
| EV / FCF | 81.22 |
Financial Position
The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.23.
| Current Ratio | 2.61 |
| Quick Ratio | 2.25 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 2.54 |
| Debt / FCF | 2.33 |
| Interest Coverage | 10.22 |
Financial Efficiency
Return on equity (ROE) is 8.43% and return on invested capital (ROIC) is 3.46%.
| Return on Equity (ROE) | 8.43% |
| Return on Assets (ROA) | 2.65% |
| Return on Invested Capital (ROIC) | 3.46% |
| Return on Capital Employed (ROCE) | 5.00% |
| Revenue Per Employee | 2.02M |
| Profits Per Employee | 200,446 |
| Employee Count | 5,659 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, HKG:1801 has paid 86.32 million in taxes.
| Income Tax | 86.32M |
| Effective Tax Rate | 6.50% |
Stock Price Statistics
The stock price has increased by +115.30% in the last 52 weeks. The beta is 0.46, so HKG:1801's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +115.30% |
| 50-Day Moving Average | 86.71 |
| 200-Day Moving Average | 78.57 |
| Relative Strength Index (RSI) | 38.02 |
| Average Volume (20 Days) | 13,552,413 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1801 had revenue of HKD 12.52 billion and earned 1.24 billion in profits. Earnings per share was 0.74.
| Revenue | 12.52B |
| Gross Profit | 9.59B |
| Operating Income | 1.02B |
| Pretax Income | 1.33B |
| Net Income | 1.24B |
| EBITDA | 1.43B |
| EBIT | 1.02B |
| Earnings Per Share (EPS) | 0.74 |
Balance Sheet
The company has 10.45 billion in cash and 3.70 billion in debt, giving a net cash position of 6.75 billion or 3.92 per share.
| Cash & Cash Equivalents | 10.45B |
| Total Debt | 3.70B |
| Net Cash | 6.75B |
| Net Cash Per Share | 3.92 |
| Equity (Book Value) | 15.80B |
| Book Value Per Share | 9.56 |
| Working Capital | 8.85B |
Cash Flow
In the last 12 months, operating cash flow was 1.99 billion and capital expenditures -404.04 million, giving a free cash flow of 1.59 billion.
| Operating Cash Flow | 1.99B |
| Capital Expenditures | -404.04M |
| Free Cash Flow | 1.59B |
| FCF Per Share | 0.92 |
Margins
Gross margin is 76.62%, with operating and profit margins of 8.14% and 9.91%.
| Gross Margin | 76.62% |
| Operating Margin | 8.14% |
| Pretax Margin | 10.60% |
| Profit Margin | 9.91% |
| EBITDA Margin | 11.40% |
| EBIT Margin | 8.14% |
| FCF Margin | 12.67% |
Dividends & Yields
HKG:1801 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.74% |
| Shareholder Yield | -3.74% |
| Earnings Yield | 0.92% |
| FCF Yield | 1.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:1801 has an Altman Z-Score of 4.57 and a Piotroski F-Score of 8.
| Altman Z-Score | 4.57 |
| Piotroski F-Score | 8 |